Antinuclear antibody testing in a Turkish pediatrics clinic: is it always necessary?

Clicks: 301
ID: 4122
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #30 of 76 articles by views in The Pan African medical journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The term anti-nuclear antibody (ANA) is used to define a large group of autoantibodies which specifically bind to nuclear elements. Although healthy individuals may also have ANA positivity, the measurement of ANA is generally used in the diagnosis of autoimmune disorders. However, various studies have shown that ANA testing may be overused, especially in pediatrics clinics. Our aim was to investigate the reasons for antinuclear antibody (ANA) testing in the general pediatrics and pediatric rheumatology clinics of our hospital and to determine whether ANA testing was ordered appropriately by evaluating chief complaints and the ultimate diagnoses of these cases.The medical records of pediatric patients in whom ANA testing was performed between January 2014 and June 2016 were retrospectively evaluated. Subjects were grouped according to the indication for ANA testing and ANA titers.ANA tests were ordered in a total of 409 patients during the study period, with 113 positive ANA results. The ANA test was ordered mostly due to joint pain (50% of the study population). There was an increased likelihood of autoimmune rheumatic diseases (ARDs) with higher ANA titer. The positive predictive value of an ANA test was 16% for any connective tissue disease and 13% for lupus in the pediatric setting.in the current study, more than one-fourth of the subjects were found to have ANA positivity, while only 15% were ultimately diagnosed with ARDs. Our findings underline the importance of an increased awareness of correct indications for ANA testing.
Reference Key
aygun2019antinuclearthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Aygün, Erhan;Kelesoglu, Fatih Mehmet;Dogdu, Gafur;Ersoy, Aysenur;Basbug, Dilruba;Akça, Dilara;Çam, Özge Nur;Akyüz, Berat;Günsay, Tülay;Kapici, Ahmet Hakki;Aydin, Nur Gökçe;Karapinar, Edanur;Atay, Sirin;Saglam, Nesibe;Okumus, Nazli Kübra;Can, Melike Zeynep;Yazici, Fatmatüzzehra;Ömeroglu, Rukiye Eker;
Journal The Pan African medical journal
Year 2019
DOI
10.11604/pamj.2019.32.181.13793
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.